This investigation has raised concerns about potential legal and reputational ... the approval process for Pfizer’s vaccine candidates. Despite these challenges, Pfizer maintains a Moderate ...

Smith’s activist challenge got off to a shambolic ... Smith then accused Pfizer of threatening the pair with legal action to get the former executives to change their tune.

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE ... rebounded after Wall Street analysts highlighted the significant legal challenges the order would face. The pharmaceutical industry has ...

Court revives lawsuit against Pfizer's diversity fellowship Group ... it issued last year holding the organization lacked legal standing to challenge the drugmaker's program in court.

In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...

Pfizer defended the initiative ... this complaint fits a larger wave of legal challenges to diversity programs.

Despite facing legal challenges and investor pressure, such as litigation related to Oxbryta and interactions with activist investor Starboard, Pfizer has remained resilient. Its strategic ...

Pfizer's historical legal issues and lobbying activities could lead to RICO charges if RFK Jr. uncovers evidence of fraudulent practices. Despite potential risks, Pfizer's low P/E ratio and robust ...

David Risinger has given his Hold rating due to a combination of factors surrounding Pfizer’s current financial ... stems from projected revenue growth challenges over the next five years ...